Low-Dose Lorazepam in the Treatment of Catatonia
Prim Care Companion CNS Disord
.
2022 Nov 3;24(6):22cr03264.
doi: 10.4088/PCC.22cr03264.
Authors
Mollie C Marr
1
,
Matthew Staropoli
1
,
Paul Bonney
1
,
Joseph Chien
1
2
Affiliations
1
Oregon Health and Science University, Portland, Oregon.
2
Corresponding author: Joseph Chien, DO, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239 (jocn16@gmail.com).
PMID:
36343355
DOI:
10.4088/PCC.22cr03264
No abstract available
MeSH terms
Catatonia* / drug therapy
Humans
Lorazepam* / therapeutic use
Substances
Lorazepam